Yitzhak Beigel

Medicine & Life Sciences

1. Hyperlipoproteinemia Type II 100%
2. Hypercholesterolemia 84%
3. Plasma Exchange 81%
4. Cholesterol 55%
5. Lovastatin 50%
6. Blood Component Removal 49%
7. Adhesiveness 47%
8. Cell Aggregation 45%
9. Erythrocytes 42%
10. Fibrinogen 41%
11. Erythrocyte Aggregation 39%
12. Lipids 38%
13. LDL Lipoproteins 32%
14. Lipoproteins 30%
15. Dextran Sulfate 29%
16. Blood Platelets 24%
17. Atherosclerosis 23%
18. Triglycerides 22%
19. Therapeutics 22%
20. Rheology 22%
21. Apolipoproteins A 21%
22. Uroporphyrinogen Decarboxylase 19%
23. LDL Cholesterol 19%
24. Hepatic Infarction 19%
25. Fish Oils 19%
26. Insulin Resistance 19%
27. Apoproteins 19%
28. Hydroxymethylglutaryl-CoA Reductase Inhibitors 19%
29. Hypertriglyceridemia 19%
30. Abetalipoproteinemia 19%
31. Human ApoE protein 19%
32. apolipoprotein A-IV 18%
33. cerivastatin 18%
34. Chylous Ascites 18%
35. oxidized low density lipoprotein 18%
36. Histiocytic Sarcoma 17%
37. Israel 17%
38. Homocysteine 17%
39. Jews 16%
40. Placebos 16%
41. Agammaglobulinemia 16%
42. Chronic Granulomatous Disease 16%
43. Serum 16%
44. Corynebacterium 15%
45. Pravastatin 15%
46. Garlic 15%
47. Lupus Coagulation Inhibitor 15%
48. Aminolevulinic Acid 15%
49. Porphyrins 15%
50. Thyrotoxicosis 15%